Boston, MA -- (SBWire) -- 06/21/2017 --Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Malaria - Pipeline Review, H1 2017, provides an overview of the Malaria (Infectious Disease) pipeline landscape.
Malaria is a life-threatening blood disease caused by a parasite (Plasmodium) that is transmitted to humans by the Anopheles mosquito. People at increased risk of serious disease include young children and infants, travelers coming from areas with no malaria and pregnant women and their unborn children. Symptoms may include fever, chills, headache, sweats, fatigue, enlarged spleen, nausea and vomiting. Treatment includes anti-malarial medicines and healthy lifestyle.
Get More Details on this Report and a Full Table of Contents at Malaria - Pipeline Review, H1 2017
Report Highlights
Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Malaria - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Malaria (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Malaria (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Malaria and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are 2, 12, 10, 55 and 31 respectively. Similarly, the Universities portfolio in Phase III, Phase II, Phase I, Preclinical and Discovery stages comprises 1, 3, 11, 45 and 41 molecules, respectively.
Malaria (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.
Report Scope
-The pipeline guide provides a snapshot of the global therapeutic landscape of Malaria (Infectious Disease).
-The pipeline guide reviews pipeline therapeutics for Malaria (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
-The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
-The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
-The pipeline guide reviews key companies involved in Malaria (Infectious Disease) therapeutics and enlists all their major and minor projects.
-The pipeline guide evaluates Malaria (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
-The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
-The pipeline guide reviews latest news related to pipeline therapeutics for Malaria (Infectious Disease)
Reasons to Get this Report
-Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
-Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
-Find and recognize significant and varied types of therapeutics under development for Malaria (Infectious Disease).
-Classify potential new clients or partners in the target demographic.
-Develop tactical initiatives by understanding the focus areas of leading companies.
-Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
-Formulate corrective measures for pipeline projects by understanding Malaria (Infectious Disease) pipeline depth and focus of Indication therapeutics.
Companies Mentioned in this Report: 4SC AG, Actelion Ltd, Agilvax Inc, Akshaya Bio Inc, Alfa Wassermann SpA, Allergy Therapeutics Plc, Altimmune Inc, Amura Holdings Ltd, Anacor Pharmaceuticals Inc, Artificial Cell Technologies Inc, AstraZeneca Plc, Atreca Inc, Bharat Biotech International Ltd, Carna Biosciences Inc, CEL-SCI Corp, Celgene Corp, Cilian AG, Daiichi Sankyo Company Ltd, DesignMedix Inc, Eisai Co Ltd, GenVec Inc, Genzyme Corp, GeoVax Labs Inc, GlaxoSmithKline Plc, Griffith University, Hager Biosciences LLC, iBio Inc, Ichor Medical Systems Inc, Imaxio SA, Immtech Pharmaceuticals Inc, Immunovaccine Inc, IPCA Laboratories Ltd, IRBM Science Park SpA, Jenrin Discovery Inc, Jomaa Pharma GmbH, Kancera AB, Kymab Ltd, Lipocure Ltd, Lipotek Pty Ltd, LondonPharma Ltd, Marinomed Biotechnologie GmbH, Merck & Co Inc, Merck KGaA, MerLion Pharmaceuticals Pte Ltd, Microbiotix Inc, Mitsubishi Tanabe Pharma Corp, Mucosis BV, Mymetics Corp, Novartis AG, PaxVax Inc, Pfizer Inc, Protein Potential LLC, Rodos BioTarget GmbH, Sanaria Inc, Sanofi, SBI Pharmaceuticals Co Ltd, Selecta Biosciences Inc, Takeda Pharmaceutical Company Ltd, Theravectys SA, Tomegavax Inc, Toyama Chemical Co Ltd, VLP Biotech Inc, VLP Therapeutics LLC, Zydus Cadila Healthcare Ltd
About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.
Browse all Drug Pipeline research reports at Fast Market Research
You may also be interested in these related reports:
-Herpes Zoster (Shingles) - Pipeline Review, H1 2017
-Bronchitis - Pipeline Review, H1 2017
-Gastric Cancer - Pipeline Review, H1 2017
-Amyotrophic Lateral Sclerosis - Pipeline Review, H1 2017
-Non-Alcoholic Steatohepatitis - Pipeline Review, H1 2017
Malaria - Pipeline Review, H1 2017 - New Market Study Published
Fast Market Research announces the availability of the new Global Markets Direct report, "Malaria - Pipeline Review, H1 2017", on their comprehensive research portal